FibroBiologics, LLC
Charleston, SC · Founded 2021 · CIK 0001958777 · Biotech · Public
M10, a novel synthetic peptide therapeutic for antifibrotic treatment
fibrobiologics.com →- Grants
- $858K
- 3 awards
- Sector median: 1
- Raised
- $11M
- 5 Form D · Sep 2026
- 0 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2021202220232024202520262027
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Preclinical Development of M10 as a Therapeutic Agent for Scleroderma | $252,010 | |
| Federal grant | Department of Health and Human Services · Phase I · Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis | $299,295 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Novel Therapeutic Agent for Skin Fibrosis | $306,518 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $1,500,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $4,000,000 | |
| Private capital raised | Form D · SEC | $1,725,001 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $500,001 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2224 | ArriVent Biopharma | — | $191M |
| 2225 | MOBIUS SCIENTIFIC INC. | — | — |
| 2226 | PMV Pharmaceuticals | — | $74M |
| 2227 | FibroBiologics, LLC | — | $11M |
| 2228 | Diagonal Therapeutics | — | — |
| 2229 | Nimbus Therapeutics | — | — |
| 2230 | Inflection Medicine | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard CilentoDirector
- Stacy CoenDirector
- Jason DavisExecutive Officer
- Robert HoffmanDirector
- Matthew LinkDirector
- Victoria NiklasDirector
- Pete O'HeeronDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.